An introduction to chimeric antigen receptor-natural killer (CAR-NK) cell therapy

Chimeric antigen receptor (CAR) T-cell therapies are effective immunotherapeutic tools for combating cancer with genetically modified cancer-specific receptors. The effectiveness of cancer treatment is likely to fuel the global market growth of CAR T-cell therapy in the years to come. Lately, CAR-natural Killer (NK) cell therapies have also come into focus as novel therapeutic options to address hurdles related to CAR T-cell therapies, such as potential therapy-induced side effects, high price tags and slow manufacturing.

Copy and paste this URL:

https://biopharma.labcorp.com/latest-thinking/explore-library/detail.html/covance/assetLibrary/whitepapers/Chimeric-Antigen-Receptor-Natural-Killer-Cell-Therapy-WPCGT004.pdf